Form 4: Penumbra Director Sells Shares Under Pre-Arranged Trading Plan

Penumbra Inc. Director Bridget O'Rourke sold 50 shares of common stock for $259.78 per share on June 16, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Summary

• Bridget O'Rourke, a Director of Penumbra Inc. (PEN), reported a transaction involving the sale of common stock.
• The transaction occurred on June 16, 2025.
• A total of 50 shares of Penumbra Common Stock were disposed of.
• The shares were sold at a price of $259.78 per share.
• Following this transaction, Bridget O'Rourke beneficially owns 5,373 shares of Penumbra Common Stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating it was pre-scheduled.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, the small quantity (50 shares) and the execution under a Rule 10b5-1 plan suggest it's a routine, pre-planned transaction rather than a signal of negative company prospects.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, which suggests a pre-planned and systematic disposition of shares rather than a reaction to new, negative information.

Negatives

• A director selling shares, even a small amount, can sometimes be perceived negatively by investors, though the Rule 10b5-1 plan mitigates this concern.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends. It is a routine disclosure required for directors and officers of publicly traded companies.

Stakeholder Impact

• Shareholders: A minor sale by a director, especially under a 10b5-1 plan, is unlikely to have a significant impact on shareholder sentiment or the stock price. It's a routine disclosure.

Key Dates

Keywords

Penumbra Inc., PEN, Form 4, Insider Trading, Stock Sale, Director, Bridget O'Rourke, Rule 10b5-1 Plan, Common Stock